Siemens' molecular testing systems enable precise detection of major infectious diseases; monitoring of treatment efficacy; and selection of targeted, individualized treatment options. The combination of infectious disease immunoassay and molecular testing offers a total solution for diagnosis and monitoring of HIV and hepatitis.
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.